Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Wednesday, 16 January 2019, 10:30 HKT/SGT
Share:
    

Source: Holista CollTech Ltd
Two Malaysian Companies to Develop Breakthrough Low GI Roti Canai

PERTH/KUALA LUMPUR, Jan 16, 2019 - (ACN Newswire) - Food ingredient specialist Holista CollTech Ltd (ASX:HCT, "Holista") has partnered Bursa Malaysia-listed Kawan Food Berhad ("Kawan Food") to produce healthy Asian flatbreads, including roti canai, roti and chappati, for local and international markets.

Holista, which is listed in Australia and headquartered in Petaling Jaya, will use its proprietary mix of ingredients trademarked as GI Lite to develop a range of low-glycemic index ("low-GI") Indian flatbreads with Kawan Food - Malaysia's largest manufacturer and leading exporter of frozen Asian delicacies worldwide.

GI Lite added to Kawan Food range of products is expected to add up to AU$4 million to Holista's top line this year. The low-GI roti canai will be sold in Malaysia by April 2019, while sales to U.S. consumers are expected to commence in June 2019.

GI Lite has had a favorable sensory testing by Kawan Food, and Kawan Food is now starting low GI testing. The GI indicates the rate at which foods containing carbohydrates raise human blood sugar levels, with a lower score indicating healthier food. A diet high in carbohydrates is linked to diabetes, heart disease, obesity, poor energy levels, food cravings and drowsiness.

Based on Holista's previous laboratory trials, the companies expect to produce roti canai with a GI range. Holista is targeting the same results it achieves with flatbread, levels being about 40% lower than the current global average reading of 70 for flatbreads. The low-GI roti canai will also have lower fat content. Research and product trials are planned to begin this month. The testing will be done in in the University of Sydney as per international standards for Glycemic Index.

Kawan Food is a major supplier of frozen ethnic food with main product categories such as bakery, bun, chapatti, dessert, finger food, frozen vegetable, paratha and spring roll pastry. It currently exports to approximately forty (40) countries including US, Canada, UK, France, Australia and United Arab Emirates ("UAE"). Kawan Food is listed on the Malaysian Stock Exchange. It has been since 2005.

Roti canai, a breakfast favorite and staple food in Malaysia, contains significant amounts of calories and fats, exacerbating the existing problem of obesity in the country. According to the Economic Intelligence Unit, Malaysia is Asia's most obese nation with a 13.3% obesity rate.

Dato' Dr. Rajen Manicka, Managing Director and CEO of Holista, said: "We are excited to announce our partnership with Kawan Food, a home-grown producer and supplier of some of Malaysia's favourite food. Our low-GI versions of this popular staple food will help to address the growing problem of obesity and diabetes in Malaysia and abroad."

Holista's clean-label (all-natural) formula comprises a blend of okra, barley, lentils and fenugreek. When mixed with white flour, it lowers the GI reading of the final product without compromising taste or texture.

Mr. Timothy Tan, Managing Director of Kawan Food, said, "We are proud to work with Holista to be the first in the world to offer healthy flatbreads such as roti canai, effectively carving out a new niche in the food ingredients sector in Malaysia and beyond."

For further information, please contact:

Corporate Affairs & Business Opportunities
Dr Rajen Manicka: [email protected]
General Enquiries: [email protected]

Australia
283 Rokeby Road
Subiaco WA 6008
P: +61 8 6141 3500 ; F: +61 8 6141 3599

Malaysia
12th Floor, Amcorp Trade Centre, PJ Tower
No. 18, Persiaran Barat off Jalan Timur
46000, Petaling Jaya, Malaysia
P: +603 7965 2828 ; F: +603 7965 2777

Media and Investor Relations Enquiries
WeR1 Consultants Pte Ltd
3 Phillip Street #12-01
Singapore 048693
E: [email protected]; P: +65 67374844

About Holista CollTech Ltd

Holista CollTech Ltd (Holista) is a research-driven biotech company and is the result of the merger of Holista Biotech Sdn Bhd and CollTech Australia Ltd. Headquartered in Perth with extensive operations in Malaysia, Holista is dedicated to delivering first-class natural ingredients and wellness products and leads in research on herbs and food ingredients.

Holista, listed on the Australia Securities Exchange, researches, develops, manufactures and markets "health-style" products to address the unmet and growing needs of natural medicine. Holista's suite of ingredients is capable of serving the industry to provide low-GI baked products, low sodium salt, low fat fried foods and low calories sugar without compromise in taste, odour and mouth feel. It is the only company to produce sheep (ovine) collagen using patented extraction methods.

Full press release (PDF): http://www.acnnewswire.com/clientreports/598/20191601_HCT_Kawan_Food.pdf


Jan 16, 2019 10:30 HKT/SGT
Topic: Press release summary
Sectors: Food/Beverage, Daily News, BioTech, HealthCare, Cosmetics/Spec.Chem
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2019 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Holista CollTech Ltd
July 24, 2019 15:00 HKT/SGT
Global BioLife Inc.'s Naturally Modified Sugar Laetose(TM) Unveiled at Harvard Global Health Summit
Jan 28, 2019 12:00 HKT/SGT
Singapore eDevelopment subsidiary Global BioLife's 3F Antimicrobial Fragrance shows Efficacy against Tuberculosis
Feb 14, 2018 17:00 HKT/SGT
Holista Group Company signs US$6M MOU to supply Low-GI Noodle Mix to Wing's of Canada
Oct 24, 2017 18:00 HKT/SGT
SGX-Listed Singapore eDevelopment's Global BioLife Inc Develops Breakthrough Modified Sugar
Oct 19, 2017 16:00 HKT/SGT
ASX-Listed Holista and Holista Foods Inc. (USA) Develop Breakthrough Noodle Formula with Low-Glycemic Score of 38
Aug 15, 2017 19:00 HKT/SGT
Singapore eDevelopment's Global BioLife and U.S.-based Chemia Corporation to Develop Functional Fragrances to Fight Mosquito-Borne Diseases
May 22, 2017 11:00 HKT/SGT
Singapore eDevelopment Subsidiary Initiates Research on New Universal Drug Platform
More news >>
 News Alerts
Copyright © 2019 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 6859 8575

Connect With us: